Naked Short Selling: The Truth Is Much Worse Than You Have Been ToldArticle - Media
Naked Short Selling: The Truth Is Much Worse Than You Have Been Told
By James Stafford – Feb 02, 2021, 3:20 PM CST, OilPrice.com
There is a massive threat to our capital markets, the free market in general, and fair dealings overall. And no, it’s not China. It’s a homegrown threat that everyone has been afraid to talk about.
Until now. That fear has now turned into rage.
The naked truth is this: Investors stand no chance in the face of naked short sellers. It’s a game rigged in the favor of a sophisticated short cartel and Wall Street giants.
Continue reading “Naked Short Selling: The Truth Is Much Worse Than You Have Been Told”
Subject: Andrew LeftSubject of Interest
Andrew Edward Left is an activist short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com. Left is known for advising investors on short selling and has often appeared on various media outlets such as CNBC and Bloomberg to talk about his opinions on stocks. In 2016, Left was banned for five years by the Hong Kong Market Misconduct Tribunal for disclosing false or misleading information, and so inducing transactions under the Securities and Futures Ordinance.
Tip: Is Peloton Ripe for a Naked Short Selling Attack from Andrew Left and Citron?Tip
Chart and Articles for Peloton Today
Comment: Watch LEFT and his $5 target on stock its $44. Like i said he put out his BullShit report the people panic and sell and he makes a quick profit you know they are not short anymore. FOLLOW HIS SELL TICKETS in PTON I bet you will see the Sells and 10 minutes after the attack and report is out THEY COVER
Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?Release
Citron Research Further Criticizes Inovio Pharmaceuticals, Inc.; Investors Who Lost Money Should Contact Block & Leviton LLP Who Filed First Shareholder Lawsuit
Global Newswire, 27 April 2020
BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.
Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target SHORT AND DISTORT for a quick profit
Continue reading “Release: Andrew Left Naked Short Selling Inovio? Block & Leviton in Collusion Defaming and Committing Tortious Interference?”
Article: One of Wall Street’s most notorious short-sellers says Peloton will plummet 86%, citing ‘intense’ competition (PTON)Article - Media
One of Wall Street’s most notorious short-sellers says Peloton will plummet 86%, citing ‘intense’ competition (PTON)
MarketInsider, 10 December 2019
- Citron Research, run by the famed short-seller Andrew Left, slapped Peloton with a $5 price target on Tuesday.
- That would imply an 86% drop from Monday’s close of $34.77.
- Citron argued that the losses would come amid “intense” competition that’s mounting.
- Shares of Peloton fell as much as 9.1% on Tuesday.
Comment: Yelling fire in a crowded theatre is a crime A short and distort SELL REPORT How about selling his sell tickets IS he still short? his target is $5 right I bet he covered 10 min after his report . Andrew Left should be under investigation. His recommendations should be compared to his positions.
Article: Avoid Namaste (TSXV:N) Stock at All CostsArticle - Media, Publications
Avoid Namaste (TSXV:N) Stock at All Costs
Adam Othman, 13 August 13 2019
Namaste Technologies (TSXV:N) seemed like the company to promise an online cannabis platform that could cater to the needs of the increasingly massive cannabis industry. The reality of the situation is far away from the potential the company had.
The cannabis-centred e-commerce technology company fired its CEO, Sean Dollinger, earlier this year, following Citron Research’s report that put a sizable dent in the share price of Namaste. The company was accused of making fake claims of a Nasdaq listing in order to get investors to buy stock. The company’s board sprang into action to form a special committee to investigate the claims.
Continue reading “Article: Avoid Namaste (TSXV:N) Stock at All Costs”
Article: Citron’s Andrew Left slams Jumia as a ‘fraud,’ accuses company of ‘financial colonialism’ in latest videoArticle - Media
Citron’s Andrew Left slams Jumia as a ‘fraud,’ accuses company of ‘financial colonialism’ in latest video
MarketWatch, 29 May 2019
Citron Research’s Andrew Left, a noted short seller, is once again slamming Jumia Technologies AG as a “fraud,” this time in a video that includes footage of what he says are former employees who accuse the company of placing fake orders.
Comment: Down from $36 to $3 based on a naked short selling campaign apparently led by Andrew Left.
Article: Information for Investors Who Lost Money in Village Farms International, Inc. (VFF)Article - Media, Publications
Information for Investors Who Lost Money in Village Farms International, Inc. (VFF)
Sonn Law Staff, 17 May 2019
Village Farms International, Inc. (VFF) is a Canadian-based greenhouse company.
Beyond growing common vegetables like tomatoes and peppers — a business that this company has been engaged in for many years — Village Farms International also recently become involved in the recreational marijuana industry. In recent years, the VFF stock price is up considerably — as investors consider the company’s potential to create significant revenue in a new business. However, serious questions have been raised about the company’s business model and its actual financial position. Indeed, in April of 2019, Citron Research released a report on Village Farms International arguing that federal regulators should investigate the firm for possible stock manipulation.
Continue reading “Article: Information for Investors Who Lost Money in Village Farms International, Inc. (VFF)”
Article: Short-seller Andrew Left to appeal against Hong Kong market banArticle - Media
Short-seller Andrew Left to appeal against Hong Kong market ban
Reuters, 26 February 2019
HONG KONG (Reuters) – U.S. short seller Andrew Left lost his legal bid on Tuesday to overturn a five-year ban from Hong Kong’s financial markets and a fine for market manipulation.
Left, founder of U.S.-based short-seller Citron Research, was banned in 2016 after he was found culpable of market misconduct in connection with the publication of a research report on Chinese property developer China Evergrande Group.
Article: Houston, Pot Stock Namaste Technologies Has a ProblemArticle - Media, Publications
Houston, Pot Stock Namaste Technologies Has a Problem
Sean Williams, 07 February 2019
On early Monday morning, Feb. 4, Namaste Technologies (OTC:NXTTF), a small-cap cannabis company known best for selling vaporizers and starting up a medical cannabis portal known as NamasteMD, issued a press release that announced the termination of its CEO Sean Dollinger, with cause. Before we get to the specifics of this press release and why Dollinger was relieved of his leadership role, it helps to have some background on why this press release was necessary.
Back in October, noted short-seller Citron Research, which is headed by Andrew Left, released a report alleging that Namaste Technologies was a “complete fraud.” Left accused Namaste of making a “fake claim of a Nasdaq listing to get investors to buy the stock” and, more importantly, claimed to have uncovered a related party sale tied to the company’s divestiture of Dollinger Enterprises in Nov. 2017.
Continue reading “Article: Houston, Pot Stock Namaste Technologies Has a Problem”
Article: A notorious short-seller has come out swinging against a popular marijuana stock (CRON)Article - Media
A notorious short-seller has come out swinging against a popular marijuana stock (CRON)
Business Insider, 30 August 2018
Citron Research — a short-selling firm with a history of wiping out stock prices and run by Andrew Left — has a new target: cannabis stocks.
In a report published Thursday, the firm says Cronos, one of the most valuable publicly traded marijuana companies, is worth roughly one-third of its current price: $3.50 per share.
Article: Shopify stock drops $1.5B thanks to a lone bloggerArticle - Media, Publications
Shopify stock drops $1.5B thanks to a lone blogger
Zachary Crockett, 06 October 2017
On Wednesday, investment site Citron Research published a scathing accusation that ecommerce platform Shopify — one of 2017’s best-performing tech stocks — is actually a “completely illegal get-rich-quick scheme.” According to Citron, Shopify’s method of recruiting (which involves marketing their service as a way for “partners” to easily make millions) flagrantly violates FTC rules. Shortly after the post and video were published, Shopify’s stock plummeted as much as 11.6%, chopping about $1.5B off the company’s market value.
Continue reading “Article: Shopify stock drops $1.5B thanks to a lone blogger”
Article: CEO fires back at short-seller Citron on live TV: ‘Mr. Left is dead wrong’Article - Media
CEO fires back at short-seller Citron on live TV: ‘Mr. Left is dead wrong’
Berkeley Lovelace Jr.
CNBC, 15 May 2017
Exact Sciences Chairman and CEO Kevin Conroy fired back at a bearish assessment made by Citron Research’s Andrew Left, who predicted a long-term drop in the cancer testing company’s stock to a near-zero single digit.
Citron said in a report on Monday that Exact Sciences’ Cologuard cancer test, an at home screening for colon cancer, is “inferior” and shouldn’t be pitching it as an alternative to a colonoscopy.
Comment: Andrew Left’s Citron appears to be a front for naked short sellers.
Article: Citron Research “Exposes” Exact Sciences – Short Term Target $20Article - Media
Citron Research “Exposes” Exact Sciences – Short Term Target $20
ValueWalk.com, 15 May 2017
Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half – so says a new reprot from Citron Research – Citron founder Andrew Left battled the CEO of Exact on CNBC on that topic for CNBC pro sub subscribers you can find that video here
Comment: Knocked stock down from $30 to $22. They needed to cover, stock then went to $125.